Inventor · disambiguated record
Tatsuhiko Kodama
Also filed as: KODAMA TATSUHIKO
31 granted patents·18 pending applications·223 citations·filing 1993–2024
96Inventor score
Files withKOWA CO13UNIV TOKYO12CHUGAI PHARMACEUTICAL CO LTD9SAVID THERAPEUTICS INC3IWATSUBO TAKESHI2
Top patents by PatentIndex Score
49 records- 0187US7750204B2Methods for producing antibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 2003·Granted Jul 6, 2010·19 cites·2 claims
- 0286US6395753B1Cyclic amine compounds and pharmaceutical composition containing the sameKOWA CO·Filed 2001·Granted May 28, 2002·21 cites·18 claims
- 0384US5510466AScavenger receptor protein and antibody theretoMASSACHUSETTS INST TECHNOLOGY·Filed 1994·Granted Apr 23, 1996·62 cites·17 claims
- 0482US6472386B1Cyclic diamine compound with 5-membered ring groupsKOWA CO·Filed 2001·Granted Oct 29, 2002·17 cites·14 claims
- 0581US12115223B2Conjugate of biotin-modified dimer and phthalocyanine dyeUNIV TOKYO·Filed 2021·Granted Oct 15, 2024·1 cites·20 claims
- 0679US6605620B1Cyclic amine compounds and pharmaceutical composition containing the sameKOWA CO·Filed 2002·Granted Aug 12, 2003·10 cites·6 claims
- 0778US11286285B2Modified biotin, streptavidin mutant, and usage of themSAVID THERAPEUTICS INC·Filed 2015·Granted Mar 29, 2022·2 cites·7 claims
- 0878US6867221B2Cyclic amine compounds and pharmaceutical composition containing the sameKOWA CO·Filed 2002·Granted Mar 15, 2005·11 cites·18 claims
- 0977US8394376B2Therapeutic agents for alzheimer's disease and cancerIWATSUBO TAKESHI·Filed 2010·Granted Mar 12, 2013·4 cites·2 claims
- 1076US9670255B2Modified biotin, mutant streptavidin, and use thereofSAVID THERAPEUTICS INC·Filed 2014·Granted Jun 6, 2017·2 cites·8 claims
- 1176US6552188B2Unsymmetrical cyclic diamine compoundKOWA CO·Filed 2001·Granted Apr 22, 2003·9 cites·41 claims
- 1275US8013208B2Methods for producing antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2010·Granted Sep 6, 2011·1 cites·43 claims
- 1374US8546537B2Streptavidin having low immunogenicity and use thereofKODAMA TATSUHIKO·Filed 2010·Granted Oct 1, 2013·5 cites·10 claims
- 1473US6632810B2Cyclic diamine compound with condensed-ring groupsKOWA CO·Filed 2001·Granted Oct 14, 2003·5 cites·19 claims
- 1571US6498169B1Cyclic amine compounds and pharmaceutical composition containing the sameKOWA CO·Filed 2001·Granted Dec 24, 2002·4 cites·21 claims
- 1671US5750825AMouse with defective endotheline-1 gene functionCHUGAI PHARMACEUTICAL CO LTD·Filed 1993·Granted May 12, 1998·34 cites·5 claims
- 1770US8637274B2Inhibitor for the formation of gamma-secretase complexURANO YASUOMI·Filed 2009·Granted Jan 28, 2014·4 cites·5 claims
- 1870US7731960B2Antibodies that inhibit transport activity of peptide transportersCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Granted Jun 8, 2010·1 cites·10 claims
- 1970US6509329B1Cyclic diamine compound with 6-membered ring groupsKOWA CO·Filed 2001·Granted Jan 21, 2003·4 cites·17 claims
- 2068US8398981B2Therapeutic agents for alzheimer's disease and cancerIWATSUBO TAKESHI·Filed 2011·Granted Mar 19, 2013·1 cites·1 claims
- 2166US11161884B2Modified biotin, streptavidin mutant, and usage of themSAVID THERAPEUTICS INC·Filed 2019·Granted Nov 2, 2021·0 cites·9 claims
- 2262US2024374747A1Fusion protein of vhh antibody and streptavidin mutantUNIV TOKYO·Filed 2024·Application pending·0 cites
- 2361US2007161700A1Inhibitor for the formation of y-secretase complexNISSAN CHEMICAL IND LTD·Filed 2004·Application pending·0 cites
- 2459US7666998B2Cell growth inhibitor containing anti-PepT antibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Granted Feb 23, 2010·1 cites·23 claims
- 2556US7329509B2Method for expressing a functional membrane-bound receptor protein using budded baculovirusTOUDAI TLO LTD·Filed 2002·Granted Feb 12, 2008·2 cites·7 claims
- 2655US2009220524A1Therapeutic agents for alzheimer's disease and cancerUNIV TOKYO·Filed 2007·Application pending·0 cites
- 2754US7135473B2Cyclic diamine compound with condensed-ring groupsKOWA CO·Filed 2003·Granted Nov 14, 2006·0 cites·10 claims
- 2854US2024190994A1Fusion protein between antigen-binding molecule and streptavidin variantUNIV TOKYO·Filed 2022·Application pending·0 cites
- 2952US8252524B2Method of screening pharmaceutical compositions that promote nuclear transfer of Cdc42 proteinKOHRO TAKAHIDE·Filed 2009·Granted Aug 28, 2012·0 cites·2 claims
- 3052US7964767B2Transgenic mice expressing baculovirus soluble GP64 and methods of using such mice to make antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2005·Granted Jun 21, 2011·0 cites·14 claims
- 3152US2008161348A1Ptx3-gene expression inhibitorKOWA CO·Filed 2007·Application pending·0 cites
- 3251US2022348681A1Fused protein of an antibody which recognizes cancer-cells and a streptavidin mutantUNIV TOKYO·Filed 2021·Application pending·0 cites
- 3350US2023241257A1Biotin-modified dimer and use thereofUNIV TOKYO·Filed 2021·Application pending·0 cites
- 3450US2023125454A1Conjugate of phthalocyanine dye and antibody or peptideUNIV TOKYO·Filed 2021·Application pending·0 cites
- 3549US2023149558A1Duocarmycin derivative and use thereofUNIV TOKYO·Filed 2021·Application pending·0 cites
- 3647US2022016245A1Conjugate of biotin-modified dimer and phthalocyanine dyeUNIV TOKYO·Filed 2019·Application pending·0 cites
- 3746US2003203392A1Screening method for SREBP pathway-specific inhibitorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2003·Application pending·0 cites
- 3846US2003195167A1PTX3-gene expression inhibitorKOWA CO·Filed 2002·Application pending·0 cites
- 3945US2022073641A1Fusion protein of antibody that recognizes cancer cells and mutant streptavidinUNIV TOKYO·Filed 2019·Application pending·0 cites
- 4044US2006276486A1Lklf/klf2 gene expression promoterNISSAN CHEMICAL IND LTD·Filed 2004·Application pending·0 cites
- 4142US2005176764A1Medicine for treating cancerKOWA CO·Filed 2003·Application pending·0 cites
- 4242US2007293535A1Nuclear Transfer Promoter for Ddc42 Protein and Method of Screening the DameKOWA CO·Filed 2005·Application pending·0 cites
- 4341US2010247539A1Antibodies that Inhibit Transport Activity of Peptide TransportersCHUGAI PHARMACEUTICAL CO LTD·Filed 2010·Application pending·0 cites
- 4439US7070978B2Method for expressing and purifying proteins using budded baculovirusTOUDAI TLO LTD·Filed 2001·Granted Jul 4, 2006·0 cites·22 claims
- 4539US2021214376A1Halogenated biotin-modified dimer and use thereofUNIV TOKYO·Filed 2019·Application pending·0 cites
- 4633US7955807B2Method of measuring PTX3 with high sensitivityUNIV TOKYO·Filed 2006·Granted Jun 7, 2011·0 cites·20 claims
- 4732US8309574B2Nuclear transfer promoter for Rac protein and method of screening the sameKOHRO TAKAHIDE·Filed 2005·Granted Nov 13, 2012·0 cites·3 claims
- 4832US6602710B1Screening method for SREBP pathway-specific inhibitorsCHUGAI PHARMACEUTICAL CO LTD·Filed 1998·Granted Aug 5, 2003·3 cites·7 claims
- 4925US5747451APeptide derivatives having binding activity to modified low density lipoproteinPROTEIN ENGINEERING RESEARCH I·Filed 1995·Granted May 5, 1998·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Tatsuhiko Kodama files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →